Search results

Found 385 pages
AUTHOR: John Pinching

Results per page

10 20 50 100

Sort by

Relevance Date

3 Jun 2020:

A whole new world

A whole new world - - Business Insights - PharmaTimes

by John Pinching|John Pinching

https://www.pharmatimes.com/business_insights/2020/a_whole_new_world

17 Nov 2022:

NICE recommends Pfizer’s Paxlovid on NHS

Therapy will be available on the NHS as a clinical treatment option for adults with COVID-19 - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/nice_recommends_pfizers_paxlovid_on_nhs_1480943

25 Nov 2022:

Depressive therapy Spravato demonstrates superior efficacy

Research supports use of Spravato nasal spray in adults with major depressive disorder - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/depressive_therapy_spravato_demonstrates_superior_efficacy_1481889

16 Nov 2022:

Evgen to investigate new SFX-01 tablet formulation

The therapy has the potential to treat neurological and oncological conditions - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/evgen_to_investigate_new_sfx-01_tablet_formulation_1480820

18 Nov 2022:

NICE recommends Sobi’s Doptelet to treat thrombocytopenia

Primary ITP is a rare autoimmune condition characterised by high platelet destruction - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/nice_recommends_sobis_doptelet_to_treat_thrombocytopenia_1481131

18 Nov 2022:

Kidney Cancer UK receives commission from NICE

The charity commissioned a two-year service quality audit of over 18,000 kidney cancer patients - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/kidney_cancer_uk_receives_commission_from_nice_1481126

24 Nov 2022:

Storm doses first patient with solid tumour drug candidate

Candidate is first molecule targeting an RNA methyltransferase enzyme to enter development - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/storm_doses_first_patient_with_solid_tumour_drug_candidate_1481821

22 Nov 2022:

Takeda findings may minimise haemophilia treatment side effects

Research from Takeda and Institute Krems Bioanalytics of IMC Krems and will help treat patients - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/takeda_findings_may_minimise_haemophilia_treatment_side_effects_1481538

9 Sep 2022:

Communication Awards entries still open!

Entering the singles categories is simple, quick and free, but hurry – the deadline is 16 September 2022 - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/communication_awards_entries_still_open!_1455146

16 Sep 2022:

Enter today! – International Clinical Researcher of the Year 2023

Celebrating excellence in clinical research for over decades. - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/enter_today!_international_clinical_researcher_of_the_year_2023_1455626